Actemra Product Overview
Katsunori Yoshizawa, Actemra Lifecycle Leader, Chugai Pharmaceutical Co., Ltd.

Removal of Conditions on Approval of Actemra for Intravenous Infusion with All Patients Surveillance
Shunji Yokoyama, Pharmacovigilance Manager, Chugai Pharmaceutical Co., Ltd.

Actemra Results of All Patients Surveillance and Its Position in RA Treatment in Japan
Tsutomu Takeuchi, M.D. Ph.D., Division of Rheumatology, School of Medicine, Keio University